Literature DB >> 687871

Potentiation of vasoconstrictor responses by 3- and 4-aminopyridine.

W E Glover.   

Abstract

1. In concentrations that are known to reduce potassium conductance in many excitable membranes, 3 and 4-aminopyridine (3-AP, 4-AP) potentiate vasoconstrictor responses of the isolated ear artery of the rabbit to noradrenaline and histamine. 2. 3- and 4-AP have no effect on the responses of potassium-depolarized arteries to noradrenaline, histamine or calcium. 3. The results suggest that the aminopyridines have no direct effect on the contractile machinery or on pharmacomechanical coupling, but cause potentiation by influencing electrical events at the cell membrane. 4. 4-AP causes a greater potentiation of the response te electrical stimulation than of the response to noradrenaline. This suggests that the aminopyridines may also cause an increase in the amount of noradrenaline released in response to sympathetic nerve stimulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687871      PMCID: PMC1668127          DOI: 10.1111/j.1476-5381.1978.tb17269.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  ELECTRICAL QUIESCENCE OF PULMONARY ARTERY SMOOTH MUSCLE DURING SYMPATHOMIMETIC STIMULATION.

Authors:  C SU; J A BEVAN; R C URSILLO
Journal:  Circ Res       Date:  1964-07       Impact factor: 17.367

2.  EFFECT OF GANGLION BLOCKING DRUGS ON THE RESPONSES OF THE RABBIT AORTIC STRIP TO ADRENALINE, NORADRENALINE AND OTHER VASOACTIVE SUBSTANCES.

Authors:  V V KELKAR; O D GULATI; S D GOKHALE
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-05-01

3.  Role of calcium in contractile excitation of vascular smooth muscle by epinephrine and potassium.

Authors:  W H WAUGH
Journal:  Circ Res       Date:  1962-12       Impact factor: 17.367

4.  Arterial muscle contraction and potassium movement in vitro.

Authors:  V E HEADINGS; P A RONDELL
Journal:  Am J Physiol       Date:  1962-01

5.  A comparison of the pharmacological properties of the three isomeric aminopyridines.

Authors:  F N FASTIER; M A McDOWALL
Journal:  Aust J Exp Biol Med Sci       Date:  1958-08

6.  Potentiation of vasoactive drugs by ganglionic blocking agents.

Authors:  B K LUM; P L RASHLEIGH
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

7.  Membrane potential and excitation-contraction coupling in the smooth muscle cells of the rabbit ear artery [proceedings].

Authors:  R Casteels; G Droogmans
Journal:  J Physiol       Date:  1976-12       Impact factor: 5.182

8.  Circulatory properties of amidine derivatives; potentiation of the vasoconstrictor-action of adrenaline.

Authors:  F N FASTIER; C S W REID
Journal:  Br J Pharmacol Chemother       Date:  1948-09

9.  The actions of aminopyridines on avian muscle.

Authors:  W C Bowman; A L Harvey; I G Marshall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

10.  Dynamics of aminopyridine block of potassium channels in squid axon membrane.

Authors:  J Z Yeh; G S Oxford; C H Wu; T Narahashi
Journal:  J Gen Physiol       Date:  1976-11       Impact factor: 4.086

View more
  2 in total

1.  Mechanism of noradrenaline potentiation by prostaglandin E2 in rat mesenteric artery.

Authors:  A S Adeagbo; D T Okpako
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

2.  Differential alteration of dopamine, acetylcholine, and glutamate release during anoxia and/or 3,4-diaminopyridine treatment.

Authors:  G B Freeman; V Mykytyn; G E Gibson
Journal:  Neurochem Res       Date:  1987-11       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.